|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang JY, Senan S, Paul MA, Mehran RJ,
Louie AV, Balter P, Groen HJ, McRae SE, Widder J, Feng L, et al:
Stereotactic ablative radiotherapy versus lobectomy for operable
stage I non-small-cell lung cancer: A pooled analysis of two
randomised trials. Lancet Oncol. 16:630–637. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khandelwal A, Bacolla A, Vasquez KM and
Jain A: Long non-coding RNA: A new paradigm for lung cancer. Mol
Carcinog. 54:1235–1251. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee S, Kopp F, Chang TC, Sataluri A, Chen
B, Sivakumar S, Yu H, Xie Y and Mendell JT: Noncoding RNA NORAD
regulates genomic stability by sequestering PUMILIO proteins. Cell.
164:69–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu H, Li J, Koirala P, Ding X, Chen B,
Wang Y, Wang Z, Wang C, Zhang X and Mo YY: Long non-coding RNAs as
prognostic markers in human breast cancer. Oncotarget.
7:20584–20596. 2016.PubMed/NCBI
|
|
7
|
Li H, Wang X, Wen C, Huo Z, Wang W, Zhan
Q, Cheng D, Chen H, Deng X, Peng C and Shen B: Long noncoding RNA
NORAD, a novel competing endogenous RNA, enhances the
hypoxia-induced epithelial-mesenchymal transition to promote
metastasis in pancreatic cancer. Mol Cancer. 16:1692017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Li XY, Hu P and Ding YS: LncRNA
NORAD contributes to colorectal cancer progression by inhibition of
miR-202-5p. Oncol Res. 2018. View Article : Google Scholar
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen W, Yang Y, Chen B, Lu P, Zhan L, Yu
Q, Cao K and Li Q: MiR-136 targets E2F1 to reverse cisplatin
chemosensitivity in glioma cells. J Neurooncol. 120:43–53. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lalevée S and Feil R: Long noncoding RNAs
in human disease: Emerging mechanisms and therapeutic strategies.
Epigenomics. 7:877–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and
De W: The long non-coding RNA HOTAIR indicates a poor prognosis and
promotes metastasis in non-small cell lung cancer. BMC Cancer.
13:4642013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH,
You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long
non-coding RNA TUG1 affects cell proliferation in human non-small
cell lung cancer, partly through epigenetically regulating HOXB7
expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Hu L, Wang J, Zhang F, Chen J, Xu
G, Wang Y and Pan Q: Low expression LncRNA TUBA4B is a poor
predictor of prognosis and regulates cell proliferation in
non-small cell lung cancer. Pathol Oncol Res. 23:265–270. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han T, Jiao F, Hu H, Yuan C, Wang L, Jin
ZL, Song WF and Wang LW: EZH2 promotes cell migration and invasion
but not alters cell proliferation by suppressing E-cadherin, partly
through association with MALAT-1 in pancreatic cancer. Oncotarget.
7:11194–11207. 2016.PubMed/NCBI
|
|
18
|
Vaitheesvaran B, Xu J, Yee J, Q-Y L, Go
VL, Xiao GG and Lee WN: The Warburg effect: A balance of flux
analysis. Metabolomics. 11:787–796. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li N and Zhan X and Zhan X: The lncRNA
SNHG3 regulates energy metabolism of ovarian cancer by an analysis
of mitochondrial proteomes. Gynecol Oncol. 150:343–354. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mirzaei H, Masoudifar A, Sahebkar A, Zare
N, Sadri Nahand J, Rashidi B, Mehrabian E, Mohammadi M, Mirzaei HR
and Jaafari MR: MicroRNA: A novel target of curcumin in cancer
therapy. J Cell Physiol. 233:3004–3015. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kumar R and Xi Y: MicroRNA, epigenetic
machinery and lung cancer. Thorac Cancer. 2:35–44. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L and Kang C: miRNA interventions
serve as ‘magic bullets’ in the reversal of glioblastoma hallmarks.
Oncotarget. 6:38628–38642. 2015.PubMed/NCBI
|
|
23
|
Gregory RI, Chendrimada TP, Cooch N and
Shiekhattar R: Human RISC couples microRNA biogenesis and
posttranscriptional gene silencing. Cell. 123:631–640. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karginov FV, Conaco C, Xuan Z, Schmidt BH,
Parker JS, Mandel G and Hannon GJ: A biochemical approach to
identifying microRNA targets. Proc Natl Acad Sci USA.
104:19291–19296. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang H, Huang G, Zhao N, Zhang T, Jiang
M, He Y, Zhou X and Jiang X: Long non-coding RNA TPT1-AS1 promotes
cell growth and metastasis in cervical cancer via acting AS a
sponge for miR-324-5p. J Exp Clin Cancer Res. 37:1692018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhuo M, Yuan C, Han T, Cui J, Jiao F and
Wang L: A novel feedback loop between high MALAT-1 and low
miR-200c-3p promotes cell migration and invasion in pancreatic
ductal adenocarcinoma and is predictive of poor prognosis. BMC
Cancer. 18:10322018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoon JH, Abdelmohsen K and Gorospe M:
Functional interactions among microRNAs and long noncoding RNAs.
Semin Cell Dev Biol. 34:9–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu HJ, Jin PY, Tang Y, Fan SH, Zhang ZF,
Wang F, Wu DM, Lu J and Zheng YL: microRNA-136 inhibits
proliferation and promotes apoptosis and radiosensitivity of
cervical carcinoma through the NF-κB pathway by targeting E2F1.
Life Sci. 199:167–178. 2018. View Article : Google Scholar : PubMed/NCBI
|
